KUBTEC is challenging the status quo of breast cancer surgery and is committed to reducing the excessive number of re-excision surgeries. Through continuous research and development of our proprietary 3D tomosynthesis technology, KUBTEC is empowering surgeons with immediate visualization of surgical margins in the operating theater, helping to reduce re-excision rates, preserve healthy breast tissue, and ultimately improve patient outcomes.

At KUBTEC we understand that one of the most important drivers of a positive outcome for breast cancer patients is ensuring clear margins at the time of surgery. This is what drives us to push the boundaries and work to set a new standard of care. Our proprietary award-winning technologies, such as 3D breast specimen tomosynthesis; advanced, high-resolution specimen X-ray imaging; and intelligent workflow management features are allowing us to do just that for every surgeon, radiologist, pathologist, pathologists’ assistant, and patient.

For further information, please review our product line at https://kubtec.com/ 

Technology

Health Care

Medical Devices

KUBTEC Medical Imaging

Vikram Butani

Eric Appelt

Susan Morandi

John Leach

Tom Siffringer

The Leadership Team at KUBTEC Medical Imaging is responsible for setting the strategic direction and vision of the company. This team drives innovation in breast cancer surgery technology by overseeing clinical sales, marketing initiatives, and research development. Their collaborative efforts aim to enhance patient outcomes through advanced imaging solutions while ensuring operational efficiency and market growth.

Leadership Team

Engineering Team

Sales Team

��

Leadership Team

About

Team members

Other teams at KUBTEC Medical Imaging

Engineering Team

Sales Team

��������

Leadership Team

About

Team members

Other teams at KUBTEC Medical Imaging

Engineering Team

Sales Team

��